These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 15915010

  • 21. Safety of formoterol after cumulative dosing via Easyhaler and Aerolizer.
    Randell J, Saarinen A, Walamies M, Vahteristo M, Silvasti M, Lähelmä S.
    Respir Med; 2005 Dec; 99(12):1485-93. PubMed ID: 16226024
    [Abstract] [Full Text] [Related]

  • 22. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B, Dhembare P, Jantikar A, Mahadik P, Gokhale P, Gogtay JA, Salvi SS.
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [Abstract] [Full Text] [Related]

  • 23. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of formoterol delivered through the Novolizer, a novel dry powder inhaler (DPI) compared with a standard DPI in patients with moderate to severe asthma.
    Otto-Knapp R, Conrad F, Hösch S, Metzenauer P, Maus J, Noga O, Petzold U, Kunkel G.
    Pulm Pharmacol Ther; 2008 May; 21(1):47-53. PubMed ID: 17475527
    [Abstract] [Full Text] [Related]

  • 25. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L, Rosenborg J, Bengtsson T, Lötvall J.
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [Abstract] [Full Text] [Related]

  • 27. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma.
    Morice AH, Peterson S, Beckman O, Osmanliev D.
    Int J Clin Pract; 2007 Nov; 61(11):1874-83. PubMed ID: 17887990
    [Abstract] [Full Text] [Related]

  • 28. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma.
    Kruse M, Rosenkranz B, Dobson C, Ayre G, Horowitz A.
    Pulm Pharmacol Ther; 2005 Nov; 18(3):229-34. PubMed ID: 15707858
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and tolerability of once-daily budesonide/formoterol pressurized metered-dose inhaler in adults and adolescents with asthma previously stable with twice-daily budesonide/ formoterol dosing.
    Kerwin EM, Oppenheimer JJ, LaForce C, Parasuraman B, Miller CJ, O'Dowd L, Goldman M.
    Ann Allergy Asthma Immunol; 2009 Jul; 103(1):62-72. PubMed ID: 19663129
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
    LaForce C, Prenner BM, Andriano K, Lavecchia C, Yegen U.
    J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
    [Abstract] [Full Text] [Related]

  • 31. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [Abstract] [Full Text] [Related]

  • 32. Comparable long-term safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma.
    Morice AH, Hochmuth L, Ekelund J, Thorén A, Puterman AS.
    Pulm Pharmacol Ther; 2008 Feb; 21(1):32-9. PubMed ID: 17118686
    [Abstract] [Full Text] [Related]

  • 33. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
    Kaae R, Agertoft L, Pedersen S, Nordvall SL, Pedroletti C, Bengtsson T, Johannes-Hellberg I, Rosenborg J.
    Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
    [Abstract] [Full Text] [Related]

  • 34. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [Abstract] [Full Text] [Related]

  • 35. Bronchoprotection with formoterol via dry powder and metered-dose inhalers in patients with asthma.
    Lipworth BJ, Sims EJ, Das SK, Morice AH, O'Connor BJ.
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):283-90. PubMed ID: 16200820
    [Abstract] [Full Text] [Related]

  • 36. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW, Colice GL, Ekholm BP, Klinger NM.
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [Abstract] [Full Text] [Related]

  • 37. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 38. Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
    Rosenkranz B, Rouzier R, Kruse M, Dobson C, Ayre G, Horowitz A, Fitoussi S.
    Respir Med; 2006 Apr; 100(4):666-72. PubMed ID: 16303295
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study.
    Morice AH, Peterson S, Beckman O, Kukova Z.
    Pulm Pharmacol Ther; 2008 Apr; 21(1):152-9. PubMed ID: 17376722
    [Abstract] [Full Text] [Related]

  • 40. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE, Gillen M, Eckerwall G, Uryniak T, Trudo FJ, Lampl KL.
    Allergy Asthma Proc; 2014 Apr; 35(2):134-40. PubMed ID: 24717790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.